A new study published in the Journal of the National Cancer Institute indicates that the customary pembrolizumab dose for treatment...
Delirium is a medical term for "sudden confusion." It is an abrupt, rapid change in mental function and can cause...
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, June 6, 2017--Based on the encouraging safety data that has emerged...
Credit: L. Alferink and S. Darwish Murad Amsterdam, The Netherlands, June 6, 2017 - Chronic liver diseases rank as the...
Apexian Pharmaceuticals Inc., a biotechnology company focused on developing novel compounds to treat cancer, has licensed all available patented and...
Two new studies of progressive, neurodegenerative diseases linked to defects in cells' mitochondria offer hope for developing a new biomarker...
Credit: JAMA Oncology PORTLAND, OR - People diagnosed with cancer gained 3.34 million years of life thanks to cancer clinical...
Joseph M. Unger, Ph.D., M.S., of the SWOG Statistical Center and the Fred Hutchinson Cancer Research Center, Seattle, Wash., and...
Monday, June 5, 2017, Chicago, Ill.: After reviewing nearly 3.7 million patient records, Cleveland Clinic researchers have shown that newly...
The cancer risk for a human mission to Mars has effectively doubled following a UNLV study predicting a dramatic increase...
CHICAGO - When it comes to making decisions about which prostate cancer treatment to choose, black and white men prioritize...
COLUMBUS, Ohio - Two immunotherapy drugs currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of...
PHILADELPHIA -- The American Association for Cancer Research (AACR) has published its first set of consensus screening recommendations for children...
(Bethesda, MD, June 05, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the...
Monica Morrow, M.D., of Memorial Sloan Kettering Cancer Center, New York, and coauthors investigated the impact of a 2014 consensus...
CATONSVILLE, MD, June 5, 2017 - Offering comprehensive health insurance plans with low deductibles and co-pay in exchange for higher...
ASCO Perspective "It's been nearly 15 years since EGFR-targeted therapies were introduced, helping extend survival for thousands of patients in...
ASCO Perspective "While it's still early, these data are a strong sign that CAR T-cell therapy can send multiple myeloma...
ASCO Perspective "The fact that this second-generation targeted treatment halted advanced lung cancer growth for more than two years while...
ASCO Perspective "The introduction and success of HER2 targeted treatment was a turning point in breast cancer care. It's promising...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.